Last reviewed · How we verify

NCT04577521

The Safety and Efficacy of Single IA-HA Injection in Patients With Knee Osteoarthritis: A Prospective Study

Completed Last updated 14 October 2020
What this trial tests

trial testing BioVisc Ortho Single in Gonarthrosis in 67 participants. Completed in 29 January 2020.

Timeline
4 March 2019
Primary endpoint
29 January 2020
29 January 2020

Quick facts

Lead sponsorGoztepe Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment67
Start date4 March 2019
Primary completion29 January 2020
Estimated completion29 January 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Goztepe Training and Research Hospital

Who can join

18 and older, any sex, with Gonarthrosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective study was planned to carried out among the patients with grade II and III (Kellgren Lawrence classification) osteoarthritis of the knee attending outpatients clinic to evaluate the effectiveness and safety of viscosupplementation with intra-articular hyaluronic acid injection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Gonarthrosis

Currently open trials in the same condition.

Other Goztepe Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04577521.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing